Stability and Environmental Testing Services

The contract involves performing stability, sterility, biocompatibility, and environmental testing on an analgesic device to ensure compliance with FDA and ISO regulatory standards, with the explicit purpose of supporting formal regulatory submissions. All testing must adhere strictly to established protocols and quality systems required by international and U.S. health authorities to validate the device’s safety, performance, and shelf life under anticipated use conditions. The work is to be conducted at the designated place of performance in Frederick, Maryland, with a response deadline of July 30, 2026, and is classified as a subcontract under NAICS code 541620 for scientific testing and analysis services. The contracting agency is the Defense Health Agency under the Department of Defense, indicating the device is intended for military or veteran healthcare applications, and all deliverables must align with the agency’s regulatory and operational requirements.